Canada markets close in 2 hours 39 minutes

NuGen Medical Devices Inc. (NGMD.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.10000.0000 (0.00%)
As of 03:59PM EDT. Market open.
Currency in CAD

Valuation Measures4

Market Cap (intraday) 19.90M
Enterprise Value 27.32M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)50.59
Price/Book (mrq)N/A
Enterprise Value/Revenue 82.44
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 2.73
52-Week Change 3-50.00%
S&P500 52-Week Change 326.43%
52 Week High 30.2550
52 Week Low 30.0900
50-Day Moving Average 30.1177
200-Day Moving Average 30.1204

Share Statistics

Avg Vol (3 month) 3324.56k
Avg Vol (10 day) 3117.64k
Shares Outstanding 5199.03M
Implied Shares Outstanding 6199.03M
Float 8198.54M
% Held by Insiders 17.91%
% Held by Institutions 10.00%
Shares Short (Apr 30, 2024) 446.5k
Short Ratio (Apr 30, 2024) 40.33
Short % of Float (Apr 30, 2024) 4N/A
Short % of Shares Outstanding (Apr 30, 2024) 40.02%
Shares Short (prior month Mar 28, 2024) 485.75k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,302.32%

Management Effectiveness

Return on Assets (ttm)-72.93%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)331.4k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)667.90%
Gross Profit (ttm)N/A
EBITDA -7.44M
Net Income Avi to Common (ttm)-9.36M
Diluted EPS (ttm)-0.0500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)464.46k
Total Cash Per Share (mrq)0
Total Debt (mrq)7.88M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.40
Book Value Per Share (mrq)-0.01

Cash Flow Statement

Operating Cash Flow (ttm)-6.71M
Levered Free Cash Flow (ttm)-4.59M